Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (161-170 of 315) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatinS Ruan, M F Okcu, R C Pong, et al.
Blood|November 14, 1997
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytesJ Chandra, J Gilbreath, E J Freireich, et al.
Leukemia|November 28, 2002
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patientsJ Q Guo, H Lin, H Kantarjian, et al.
Blood|June 14, 2000
Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteinsM Konopleva, A M Tari, Z Estrov, et al.
Cancer Investigation|January 1, 1993
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapyP Valent, C Sillaber, K Geissler, et al.
Cytokines and Molecular Therapy|March 1, 1995
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)E H Estey, H M Kantarjian, S O'Brien, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.
Haematology and Blood Transfusion|January 1, 1990
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemiaB Clarkson, J Gaynor, C Little, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
Pageof 32

Showing results (161-170 of 315) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatinS Ruan, M F Okcu, R C Pong, et al.
Blood|November 14, 1997
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytesJ Chandra, J Gilbreath, E J Freireich, et al.
Leukemia|November 28, 2002
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patientsJ Q Guo, H Lin, H Kantarjian, et al.
Blood|June 14, 2000
Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteinsM Konopleva, A M Tari, Z Estrov, et al.
Cancer Investigation|January 1, 1993
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapyP Valent, C Sillaber, K Geissler, et al.
Cytokines and Molecular Therapy|March 1, 1995
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)E H Estey, H M Kantarjian, S O'Brien, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.
Haematology and Blood Transfusion|January 1, 1990
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemiaB Clarkson, J Gaynor, C Little, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
Pageof 32